COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,362 Articles (22,803 medRxiv, 8,559 bioRxiv)

Most recent first Previous |  Page 1666: Articles 16651-16660  | Next

Genetic associations with severe COVID-19
Murphy, N. M., Dite, G. S., Allman, R.
10.1101/2021.03.29.21254509 — Posted: 2021-03-31
Use of portable air cleaners to reduce aerosol transmission on a hospital COVID-19 ward
Buising, K. L., Schofield, R., Irving, L., Keywood, M., Stevens, A., Keogh, N., Skidmore, G., Wadlow, I., Kevin, K., Rismanchi, B., Wheeler, A., Humphries, R., Kainer, M., McGain, F., Monty, J., Marshall, C.
10.1101/2021.03.29.21254590 — Posted: 2021-03-31
Arrayed multicycle drug screens identify broadly acting chemical inhibitors for repurposing against SARS CoV 2
Murer, L. P., Volle, R., Andriasyan, V., Meili, N., Yang, L., Sequeira, D., Gomez-Gonzalez, A., Petkidis, A., Olszewski, D., Bauer, M., Suomalainen, M., Kuttler, F., Turcatti, G., Greber, U. F.
10.1101/2021.03.30.437771 — Posted: 2021-03-31
A protective broadly cross-reactive human antibody defines a conserved site of vulnerability on beta-coronavirus spikes
Zhou, P., Yuan, M., Song, G., Beutler, N., Shaabani, N., Huang, D., He, W.-t., Zhu, X., Callaghan, S., Yong, P., Anzanello, F., Peng, L., Ricketts, J., Parren, M., Garcia, E., Rawlings, S. A., Smith, D. M., Nemazee, D., Teijaro, J. R., Rogers, T., Wilson, I. A., Burton, D. R., Andrabi, R.
10.1101/2021.03.30.437769 — Posted: 2021-03-31
Exploring the role of glycans in the interaction of SARS-CoV-2 RBD and human receptor ACE2
Nguyen, K., Chakraborty, S., Mansbach, R., Korber, B., Gnanakaran, S.
10.1101/2021.03.30.437783 — Posted: 2021-03-31
Supramolecular cylinders target bulge structures in the 5-prime UTR of the RNA genome of SARS-CoV-2 and inhibit viral replication
Melidis, L., Hill, H. J., Coltman, N. J., Davies, S. P., Winczura, K., Chauhan, T., Craig, J. S., Garai, A., Hooper, C. A. J., Egan, R. T., McKeating, J. A., Hodges, N. J., Stamataki, Z., Grzechnik, P., Hannon, M. J.
10.1101/2021.03.30.437757 — Posted: 2021-03-31
Post-acute sequelae of COVID-19 in a non-hospitalized cohort: results from the Arizona CoVHORT
Bell, M. L., Catalfamo, C. J., Farland, L. V., Ernst, K. C., Jacobs, E. T., Klimentidis, Y. C., Jehn, M., Pogreba-Brown, K.
10.1101/2021.03.29.21254588 — Posted: 2021-03-31
Limited recovery from post-acute sequelae of SARS-CoV-2 (PASC) at eight months of a prospective cohort
DARLEY, D. R., Dore, G., Byrne, A., Plit, M., Brew, B. J., Kelleher, A. D., Matthews, G. V.
10.1101/2021.03.29.21254211 — Posted: 2021-03-31
Returning to the workplace during the COVID-19 pandemic: The concerns of Australian workers
Griffiths, D., Sheehan, L., van Vreden, C., Whiteford, P., Collie, A.
10.1101/2021.03.28.21254520 — Posted: 2021-03-31
Innate immune deficiencies in patients with COVID-19
Peyneau, M., Granger, V., Wicky, P.-H., Khelifi-Touhami, D., Timsit, J.-F., Lescure, F.-X., Yazdanpanah, Y., Tran-Dihn, A., Montravers, P., Monteiro, R., Chollet-Martin, S., Hurtado-Nedelec, M., de Chaisemartin, L.
10.1101/2021.03.29.21254560 — Posted: 2021-03-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).